UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer

Clinical cancer research, 2001-07, Vol.7 (7), p.1912-1922

2001

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer

Clinical cancer research, 2004-03, Vol.10 (6), p.1949-1955

2004

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, Administered on a Daily-times-five every-three-week Schedule in Patients with Advanced Solid Malignancies

Clinical cancer research, 2002-07, Vol.8 (7), p.2157-2166

2002

Volltextzugriff (PDF)

Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors

Clinical cancer research, 2000-05, Vol.6 (5), p.1736

2000

Volltextzugriff (PDF)

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Clinical cancer research, 2004-02, Vol.10 (4), p.1299-1305

2004

Volltextzugriff (PDF)

Influence of food intake on the bioavailability and efficacy of oral calcitonin

British journal of clinical pharmacology, 2009-04, Vol.67 (4), p.413-420

2009

Volltextzugriff (PDF)

Effect of Food on the Pharmacokinetics of Oral MMI270B (CGS 27023A), a Novel Matrix Metalloproteinase Inhibitor

Clinical cancer research, 2000-02, Vol.6 (2), p.431-433

2000

Volltextzugriff (PDF)

Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers

Journal of clinical pharmacology, 2000-03, Vol.40 (3), p.275-283

2000

Volltextzugriff (PDF)

Clinical pharmacology of lumiracoxib : A selective cyclo-oxygenase-2 inhibitor

Clinical pharmacokinetics, 2005-01, Vol.44 (12), p.1247-1266

2005

Volltextzugriff (PDF)

Influence of food intake on the bioavailability and efficacy of oral calcitinin

British journal of clinical pharmacology, 2009, Vol.67 (4), p.413-420

2009

Volltextzugriff (PDF)

Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: Results from a Phase II multicenter study

Clinical cancer research, 2004-02, Vol.10 (4), p.1299-1305

2004

Volltextzugriff (PDF)

Effect of Renal Function on the Pharmacokinetics of Valsartan

Clinical drug investigation, 1997-04, Vol.13 (4), p.207-214

1997

Volltextzugriff (PDF)

Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients

Pediatric transplantation, 2005-12, Vol.9 (6), p.780-787

2005

Volltextzugriff (PDF)

Réutilisation de code et modularité

The programming historian en français, 2023-02 (5)

2023

Volltextzugriff (PDF)

Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers

Journal of clinical pharmacology, 2000-03, Vol.40 (3), p.275-283

2000

Volltextzugriff (PDF)

Inhibition of Angiotensin-Converting Enzyme with Libenzapril in Normotensive Males

Journal of clinical pharmacology, 1994-12, Vol.34 (12), p.1177-1182

1994

Volltextzugriff (PDF)

Validation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort Study

PloS one, 2015-11, Vol.10 (11), p.e0142706-e0142706

2015

Volltextzugriff (PDF)

Androgen Receptor (AR)

Encyclopedia of Signaling Molecules, p.312-319

Volltextzugriff (PDF)

Aldesleukin

Encyclopedia of Signaling Molecules, p.280-280

Choi, Sangdun

Volltextzugriff (PDF)

Adipocyte Complement-Related 30 kDa Protein (ACRP30)

Encyclopedia of Signaling Molecules, p.223-223

Choi, Sangdun

Volltextzugriff (PDF)

IL-13 Receptor Alpha 2

Encyclopedia of Signaling Molecules, p.2548-2548

Choi, Sangdun

Volltextzugriff (PDF)

Ras Guanyl Nucleotide-Releasing Protein 1

Encyclopedia of Signaling Molecules, p.4468-4468

Choi, Sangdun

Volltextzugriff (PDF)

Wnt-1-Induced Secreted Protein

Encyclopedia of Signaling Molecules, p.6004-6004

Choi, Sangdun

Volltextzugriff (PDF)

Mannose Receptor, C-Type 2

Encyclopedia of Signaling Molecules, p.2934-2934

Choi, Sangdun

Volltextzugriff (PDF)

Centaurin-Alpha2

Encyclopedia of Signaling Molecules, p.1034-1034

Choi, Sangdun

Volltextzugriff (PDF)

1 – 25 von 717

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(499)
Mit Volltextzugriff
(536)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Biological And Medical Sciences
(35)
Medical Sciences
(30)
Life Sciences & Biomedicine
(29)
Humans
(27)
Sciences Du Langage
(20)
Female
(16)
Male
(15)
Exact Sciences And Technology
(14)
Linguistics
(14)
Humanities And Social Sciences
(12)
Middle Aged
(11)
Surgery
(11)
Adult
(10)
General Medicine
(9)
Pharmacology. Drug Treatments
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Oncology
(8)
Sciences Biologiques Et Medicales
(8)
Sciences Medicales
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer

Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer

A Phase I and Pharmacokinetic Study of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, Administered on a Daily-times-five every-three-week Schedule in Patients with Advanced Solid Malignancies

Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Influence of food intake on the bioavailability and efficacy of oral calcitonin

Effect of Food on the Pharmacokinetics of Oral MMI270B (CGS 27023A), a Novel Matrix Metalloproteinase Inhibitor

Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers

Clinical pharmacology of lumiracoxib : A selective cyclo-oxygenase-2 inhibitor

Influence of food intake on the bioavailability and efficacy of oral calcitinin

Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: Results from a Phase II multicenter study

Effect of Renal Function on the Pharmacokinetics of Valsartan

Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients

Réutilisation de code et modularité

Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers

Inhibition of Angiotensin-Converting Enzyme with Libenzapril in Normotensive Males

Validation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort Study

Androgen Receptor (AR)

Aldesleukin

Adipocyte Complement-Related 30 kDa Protein (ACRP30)

IL-13 Receptor Alpha 2

Ras Guanyl Nucleotide-Releasing Protein 1

Wnt-1-Induced Secreted Protein

Mannose Receptor, C-Type 2

Centaurin-Alpha2

Suchergebnisse filtern